T cells against self-antigens can be detected in peripheral blood of healthy individuals, although intrathymic negative selection removes most high-avidity T cells specific for self-antigens from the peripheral repertoire. Moreover, spontaneous T-cell proliferation following stimulation with autologous monocyte-derived dendritic cells (autoDCs) has been observed in vitro. In this study, we characterized the nature and immunological basis of the autoDC reactivity in the T-cell repertoire of healthy donors. We show that a minority of naive and memory CD4 + T cells within the healthy human T-cell repertoire mediates HLA-restricted reactivity against autoDCs, which behave like a normal antigen-specific immune response. This reactivity appeared to be primarily directed against myeloid lineage cells. Although cytokine production by the reactive T cells was observed, this did not coincide with overt cytotoxic activity against autoDCs. AutoDC reactivity was also observed in the CD8 + T-cell compartment, but this appeared to be mainly cytokine-induced rather than antigen-driven. In conclusion, we show that the presence of autoreactive T cells harboring the potential to react against autologous and HLA-matched allogeneic myeloid cells is a common phenomenon in healthy individuals. These autoDC-reactive T cells may help the induction of primary T-cell responses at the DC priming site.
Keywords: Autologous responses r CD4 + T cells r Dendritic cellsAdditional supporting information may be found in the online version of this article at the publisher's web-site
IntroductionAutologous or allogeneic T-cell responses against antigens that are either selectively expressed or overexpressed on malignant cells compared to normal cellular counterparts (tumor-associated antigens (TAAs)) are generally assumed to play an important role in immune surveillance against cancer and in cellular immunotherapy strategies [1][2][3][4][5]. In autologous and HLA-matched Correspondence: Dr. Inge Jedema e-mail: I.Jedema@lumc.nl allogeneic stem cell transplantation settings, these antigens will be presented and recognized in the context of self-HLA molecules on the cell membrane. When self-antigens and TAAs are expressed in the thymus, potentially harmful T cells expressing a highaffinity T-cell receptor (TCR) specific for these self-antigens or TAAs in the context of self-HLA are deleted from the Tcell repertoire during negative selection [6,7]. This impedes not only induction of autoimmunity but also antitumor immunity, thereby weakening the concept of functional immune surveillance against malignant cells in the autologous and HLAmatched setting. However, immune responses against autologous malignant cells have frequently been observed, although the functional avidity of these T cells may often be questionable [8][9][10][11][12][13].In line with the observations of autologous tumor-reactive T-cell responses, proliferation of (naive) T cells in response to autologous monocyte-derived dendritic cells (autoDCs) has also been demonstrated in in vitro ...